Phase II study of verubulin (MPC-6827) for the treatment of subjects with recurrent glioblastoma naïve to treatment with bevacizumab.
L. J. Kim
Research Funding - Myrexis
M. C. Chamberlain
Research Funding - Myrexis
J. Zhu
Research Funding - Myrexis
J. J. Raizer
Research Funding - Myrexis
S. A. Grimm
Research Funding - Myrexis
S. Phuphanich
Research Funding - Myrexis
C. E. Fadul
Research Funding - Myrexis
S. Rosenfeld
Research Funding - Myrexis
A. H. Balch
Employment or Leadership Position - Myrexis
Stock Ownership - Myrexis
C. C. Pope
Employment or Leadership Position - Myrexis
Stock Ownership - Myrexis
M. Brulotte
Employment or Leadership Position - Myrexis
Stock Ownership - Myrexis
A. A. P. Beelen
Employment or Leadership Position - Myrexis
Stock Ownership - Myrexis
L. D. Recht
Research Funding - Myrexis